Schizophrenia: Pathophysiological mechanisms - A synthesis

Brain Research Reviews

Volumn 31, Issue 2-3, 2000, Pages 401-404

  Terenius, Lars ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Etiology; Neurodevelopment; Neuropathology; Neuropharmacology; Schizophrenia

Indexed keywords

CYCLAZOCINE; DOPAMINE; NALORPHINE; NALTREXONE; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OPIATE ANTAGONIST; OPIATE RECEPTOR; PHENCYCLIDINE;

ANIMAL MODEL; BRAIN DEVELOPMENT; COGNITION; CONFERENCE PAPER; DRUG DESIGN; GENETIC TRANSCRIPTION; GENETICS; HUMAN; IMAGING; LANGUAGE; NERVE CELL NETWORK; NEUROPATHOLOGY; NEUROPHARMACOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; BRAIN; HUMANS; SCHIZOPHRENIA;

EID: 0034051897     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00057-0     Document Type: Conference Paper

References (12)

1. Coleman G.J., Bernard C.C.A., Bernard O. Bcl-2 transgenic mice with increased number of neurons have a greater learning capacity. Brain Res. 832:1999;188-194.
2. DeRisi J.L., Vishwanath R.I., Brown P.O. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science. 278:1997;680-686.
3. Friston K.J. The disconnection hypothesis. Schizophrenia Res. 30:1998;115-125.
4. Gunne L.M., Lindström L., Terenius L. Naloxone-induced reversal of schizophrenic hallucinations. J. Neural. Transm. 40:1977;13-19.
5. Hyman S.E., Nestler E.J. Initiation and adaptation: A paradigm for understanding psychotropic drug action. Am. J. Psychiatry. 153:1996;151-162.
6. Jentsch J.D., Roth R.H. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 20:1999;201-225.
7. Kornack D.R., Rakic P. Changes in cell-cycle kinetics during the development and evolution of primate neocortex. Proc. Natl. Acad. Sci. USA. 95:1998;1242-1246.
8. T.S. Kuhn, The Nature of the Scientific Revolutions, University of Chicago Press, 1962.
9. J.B. Martin (Ed.), Molecular Neurology, Scientific American, New York, 1998.
10. Pfeiffer A., Brantl V., Herz A., Emrich H.M. Psychotomimesis mediated by kappa opiate receptors. Science. 233:1986;774-776.
11. Vaux D.L., Korsmeyer S.J. Cell death in development. Cell. 96:1999;245-254.
12. You Z.-B., Herrera-Marschitz M., Nylander I., Goiny M., O'Connor W.T., Ungerstedt U., Terenius L. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis. II. Effects of dopamine D1 and D2 receptor agonists. Neuroscience. 63:1994;427-434.